Abstract
The ataxia telangiectasia (A-T) gene, ATM, predisposes affected homozygotes to a wide range of malignancies. It has been suggested that this is a consequence of the genomic instability associated with the syndrome. The elevated risk of malignancy is not, however, observed among A-T heterozygotes (except, apparently, regarding breast cancer). In this report we describe results from the study of the rare sporadic disease, T cell prolymphocytic leukaemia (T-PLL). In all individuals tested, we observed that at least one ATM allele was disrupted by rearrangement, that in many cases both alleles were disrupted and that there were additional mutations, predominantly mis-sense, that clustered toward the 3′ end of the gene corresponding to the protein’s phosphatidylinositol 3-kinase (PIK)-related domain. We conclude that the ATM gene can act as a tumour suppressor in the development of sporadic T-PLL. Our finding of a surfeit of mutations within ATM may reflect the involvement of the gene at more than one step in tumorigenesis. In particular, we suggest that the clustering of missense mutations may pertain to the late-onset character of both sporadic and A-T-related T-PLL, since the closest homologue of Atm protein is the yeast TEL1 protein that maintains telomere length. ATM inactivation may not be the initiating event in T-PLL tumorigenesis: prior mutation of another gene — perhaps TCL1 activation — may be obligate. This would explain the recessive character of T-PLL risk in A-T.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Al Saadi A, Palutke M, Krishna-Kuma G (1980) Evolution of chromosomal abnormalities in sequential cytogenetic studies of ataxia telangiectasia. Hum Genet 55: 23–29
Athma P, Rappoport R, Swift M (1996) Molecular genotyping shows that Ataxia-Telangiectasia heterozygotyes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130–134
Aurias A (1981) Analyse cytogénétique de 21 cas d’ataxie telangiëctasie. J Genet Hum 29: 235–247
Aurias A, Dutrillaux B, Buriot D, Lejeune J (1980) High frequencies of inversions and translocations of chromosome 7 and 14 in ataxia telangiectasia. Mutat Res 69: 369–374
Baer R, Heppel A, Taylor AMR, Rabbitts PH, Boulier B, Rabbitts TH (1987) The breakpoint of an inversion of chromosome 14 in a T-cell leukemia: sequences downstream of the immunoglobulin heavy chain locus are implicated in tumorigenesis. Proc Natl Acad Sci US 84: 9069–9073
Baffa R, Negrini M, Mandes B, Rugge M, Ranzani G, Hirohashi S, Croce C (1996) Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res 56: 268–272
Bartlett RJ, Walker AP Laing NG, Koh J, Secore SL, Speer MC, Pericak-Vance MA, Hung W-Y, Yamaoka LH, Siddique T, Kandt R, Roses AD (1989) Inherited deletion at Duchenne dystrophy locus in normal male. Lancet 1: 496–497
Bebb G, Glickman B, Gelmon K, Gatti R (1997) “AT risk” for breast cancer. Lancet 349:1784–1785
Boder E, Sidgwick RP (1958) Ataxia-Telangiectasia. Pediatrics 21: 526
Bonnefoyberard N, Genestier L, Flacher M, Revillard JP (1994) The phosphoprotein phosphatase calcineurin controls calcium-dependent apoptosis in B-cell lines. Eur J Immunol 24: 325–329
Bridges BA, Harnden DG (1981) Untangling ataxia telangiectasia. Nature 289: 222–223
Brito-Babapulle V, Catovsky D (1991) Inversions and tandem translocations involving chromosome 14g11 and 14q32 in T-cell prolymphocytic leukemia and T-cell leukemias in patients with ataxia-telangiectasia. Cancer Genet Cytogenet 55: 1–9
Brito-Babapulle V, Pomfret M, Matutes E, Catovsky D (1987) Cytogenetic studies on prolymphocytic leukaemia II T-cell prolymphocytic leukaemia. Blood 70: 926–931
Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Shreiber SL (1994) A mammalian protein targeted by Gl-arresting rapamycin-receptor complex. Nature 369: 756–758
Catovsky D, Galetto J, Okos A, Galton DAG, Wiltshaw E, Stathopoulos G (1973) Prolymphocytic leukaemia of B and T cell type. Lancet 2: 232–234
Cohen MM, Shamam M, Dagan J, Shmueli E, Korn J (1975) Cytogenetic investigations in families with ataxia telangiectasia. Cytogenet Cell Genet 15: 338–356
Davey MP, Bertness V, Nakahara K, Johnson JP, McBride OW, Waldmann TA, Kirsch I (1988) K Juxtaposition of the T-cell receptor a-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14,14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia telangiectasia. Proc Natl Acad Sci USA 85: 9287–9291
Davis M, Hitchcock A, Foulkes W, Campbell I (1996) Refinement of two chromosome llq regions of loss of heterozygosity in ovarian cancer. Cancer Res 56: 741–744
Duchaud E, Ridet A, Stoppa-Lyonnet D, Janin N, Moustacchi E, Rosselli F (1996) Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity. Cancer Res 56: 1400–1404
Easton DF (1994) Cancer risks in A-T heterozygotes. Int J Radiat Biol 66: S177 - S182
FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature [Genet] 15: 307–310
Foulkes W, Campbell I, Stamp G, Trowsdale J (1993) Loss of heterozygosity and amplification on chromosome llq in human ovarian cancer. Br J Cancer 67: 268–273
Gabra H, Watson V, Taylor K, Mackay J, Leonard R, Steel M, Porteous D, Smyth J (1996) Definition and refinement of a region of loss of heterozygosity at 11g233-g243 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56: 950–954
Galton DAG, Goldman JM, Wiltshaw F, Catovsky D, Kenry K, Goldenberg GJ (1974) Prolymphocytic leukaemia. Br J Haematol 27: 7–23
Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, Foroud T, Jaspers NGJ, Lange K, Lathrop GM, Leppert M, Nakamura Y, O’Connell P, Paterson M, Salser W, Sanal O, Silver J, Sparkes RS, Susi E, Weeks DE, Wei S, White R, Yoder F (1988) Localization of an ataxia-telangiectasia gene to chromosome 11q22–23. Nature 336: 577–578
Greenwell PW, Kronmal SL, Porter SE, Gassenhuber J, Obermaier B, Petes TD (1995) TELI, a gene involved in controlling telomere length in S cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell 82: 823–829
Hecht F, Hecht BK (1990) Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet 46: 9–19
Hecht F, Koler RD, Rigas DA, Dahnke GS, Case MP, Tisdale Y, Miller RW (1966) Leukaemia and lymphocytes in ataxia-telangiectasia. Lancet 2: 11–93
Hecht F, McCaw BK, Koler RD (1973) Ataxia telangiectasia: clonal growth of translocation lymphocytes. N Engl J Med 289: 286–291
Hui A, Lo KW, Leung SF, Choi PHK, Fong Y, Lee JCK, Huang DP (1996) Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Oncogene 56: 3225–3229
Iizuka M, Sugiyama Y, Shiraishi M, Jones C, Sikya T (1995) Allelic losses in human chromosome 11 in lung cancers. Genes Chromosomes Cancer 13: 40–46
Keldysh P, Dragani T, Fleischman E, Konstantinova L, Perevoschikov A, Pierotti M, Della Porta G, Kopnin B (1993) 1 lq deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes Cancer 6: 45–50
Kerangueven F, Eisinger F, Noguchi T, Allione F, Wargniez V, Eng C, Padberg G, Theillet C, Jacquemier J, Longy Mm, Sobol H, Birnbaum D (1997) Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14: 339–347
Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823
Knudson AG (1997) Hereditary cancer: theme and variations. J Clin Oncol 15: 3280–3287
Kojis TL, Schreck RR, Gatti RA, Sparkes RS (1989) Tissue specificity of chromosomal rearrangements in ataxia telangiectasia. Hum Genet 83: 347–352
Laing NG, Layton MG, Johnsen RD, Chandler DC, Mears ME, Goldblatt J, Kakulas BA (1992) Two distinct mutations in a single dystrophin gene–chance occurrence or pre-mutation? Am J Med Genet 42: 688–692
Lakin ND, Weber P, Stankovic T, Rottinhaus ST, Taylor AMR, Jackson SP (1996) Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13: 2707–2716
Louis-Bar D (1941) Sur un syndrome progressif comprenant des télangiéctasies capillaires cutanées et conjonctivales symétriques, à disposition naevoïde et de troubles cérébelleux. Confirm Neurol (Basel) 4: 32
Madani A, Choukroun V, Soulier J, Cacheux V, Claisse JF, Valensi F, Daliphard S, Cazin B, Levy V, Leblond V, Daniel M-T, Sigaux F, Stern M-H (1996) Expression of p13(MTCPl) is restricted to mature T-cell proliferations with t(X;14) translocations. Blood 87: 1923–1927
Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D (1991) Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78: 3269–3274
Mengle-Gaw L, Willard HF, Smith CIE, Hammarstrom L, Fischer P, Sherrington P, Lucas G, Thompson PW, Baer R, Rabbitts TH (1987) Human T-cell tumours containing chromosome 14 inversion or translocation with breakpoints proximal to immunoglobulin joining regions at 14q32. EMBO J 6: 2273–2280
Mengle-Gaw L, Albertson DG, Sherrington PD, Rabbitts TH (1988) Analysis of a T-cell tumor-specific breakpoint cluster at human chromsome 14q32. Proc Natl Acad Sci USA 85: 9171–9175
Metcalfe JA, Parkhill J, Campbell L, Stacey M, Biggs P, Byrd PJ, Taylor AMR (1996) Accelerated telomere shortening ataxia-telangiectasia. Nature [Genet] 13: 350–353
Meyn MS (1993) High spontaneous intrachromosomal recombination rates in ataxia telangiectasia. Science 260: 1327–1330
Meyn MS (1995) Ataxia telangiectasia and cellular responses to DNA damage. Cancer Res 55: 5991–6001
Norrback K-F, Roos G (1997) Telomeres and telomerase in normal and malignant haemopoietic cells. Eur J Cancer 33: 774–780
Pawson R, Dyer MJS, Barge R, Matutes E, Thornton PD, Emmett E, Kluin-Nelemans JC, Fibbe WE, Willemze R, Catovsky D (1997) Treatment of T-cell prolymphocytic leukaemia with human CDw52 antibody. J Clin Oncol 15: 2667–2672
Platzer M, Rotman G, Bauer D, Uziel T, Savitsky K, BarShira A, Gilad S, Shiloh Y, Rosenthal A (1997) Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res 7: 592–605
Rasio D, Negrini M, Manenti G, Dragani T, Croce C (1995) Loss of heterozygosity at chromosome 1 lq in lung adenocarcinoma: identification of three independent regions. Cancer Res 55: 3988–3991
Rowan WC, Hale G, Tite JP, Brett SJ (1995) Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes. Int Immunol 7: 69–77
Russo G, Isobe M, Gatti R, Finan J, Batuman O, Huebner K, Nowell PC, Croce CM (1989) Molecular analysis of a t(14,14) translocation in leukemic T-cells of an ataxia telangiectasia patient. Proc Natl Acad Sci USA 86: 602–606
Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NJ, Taylor AR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh YA (1995a) A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749–1752
Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G (1995b) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species Hum Mol Genet 4: 2025–2032
Seite P, Hillion J, D’Agay MF, Berger R, Larsen CJ (1993) BCL2 complex rearrangement in follicular lymphoma–translocation MBR J(H) and deletion in the VCR region of the same BCL2 allele. Oncogene 8: 3073–3080
Shaw M, Knowles M (1995) Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosomes Cancer 29: 222–233
Stern M-H, Soulier J, Rosenzwajg M, Nakahara K, Canki-Klain N, Aurias A, Sigaux F, Stern IR (1993) MTCP1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor aid locus in mature T cell proliferations. Oncogene 8: 2475–2483
Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James MR, Lichter P, Dohner H (1997) Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nature [Medicine] 3: 1155–1159
Syllaba L, Henner K (1926) Contribution à l’independence de l’athétose double idiopathique et congénitale: atteinte familiale, syndrome dystrophique, signe du reseau vasculaire conjonctival, intégrite psychique. Rev Neurol (Paris) 5: 541–562
Taylor AMR, Metcalfe JA, Thick J, Mak Y-F (1996) Leukemia and lymphoma in ataxia telangiectasia. Blood 87: 423–428
Thacker J (1994) Cellular radio sensitivity in ataxia-telangiectasia. Int J Radiat Biol 66: 587–596
Tomlinson I, Gammack A, Stickland J, Mann G, Mackie R, Kefford R, McGee JO’D (1993) Loss of heterozygosity in malignant melanoma at loci on chromosomes llq and 17 implicated in the pathogenesis of other cancers. Genes Chromosomes Cancer 7: 169–172
Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarstrom L, Webster ADB, Zaloudik J, Barbanti-Brodano G, James M, Russo G, Croce CM, Negrini M (1996a) The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumours reveals no evidence for mutation. Cancer Res 56: 2726–2732
Vorechovsky I, Luo LP, Lindblom A, Negrini M, Webster ADB, Croce CM, Hammarström L (1996b) ATM mutations in cancer families. Cancer Res 56: 4130–4133
Vorechovsky I, Luo L, Dyer MJS, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarström L, Webster ADB, Yuille MAR (1997) Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nature [Genet] 17: 96–99
Wooster R, Ford D, Mangion J, Ponder BAJ, Peto J, Easton DF, Stratton MR (1993) Absence of linkage to the ataxia telangiectasia locus in familial breast cancer. Hum Genet 92: 9194
Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D (1996) Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects and thymic lymphoma. Genes Dev 10: 2411–2422
Yuille MAR, Abraham SM, Coignet LJA, Lakin ND, Yaqub F, Matutes E, Brito-Babapulle V, Jackson SP, Dyer MJS, Catovsky D (1996a) Abnormalities of the ataxia telangiectasia gene (ATM) in T-prolymphocytic leukemia. Blood 8: 477a
Yuille MAR, Galiegue-Zouitina S, Hiorns L, Jadayel D, De Schouwer PJJC, Catovsky D, Dyer MJS, Kerckaert J-P (1996b) Heterogeneity of breakpoints at the transcriptional co-activator gene, BOB-1, in lymphoproliferative disease. Leukemia 10: 1492–1496
Yuille MAR, Coignet LA, Abraham SM, Yaqub F, Luo L, Matutes E, Brito-Babapulle V, Vorechovsky I, Dyer MJS, Catovsky D (1998) ATM is usually rearranged in T-cell prolymphocytic leukemia. Oncogene (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Yuille, M.A.R., Coignet, L.J.A. (1998). The Ataxia Telangiectasia Gene in Familial and Sporadic Cancer. In: Schwab, M., Rabes, H.M., Munk, K., Hofschneider, H.P. (eds) Genes and Environment in Cancer. Recent Results in Cancer Research, vol 154. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46870-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-46870-4_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46872-8
Online ISBN: 978-3-642-46870-4
eBook Packages: Springer Book Archive